GB2089505A - Determination of Transferrine - Google Patents

Determination of Transferrine Download PDF

Info

Publication number
GB2089505A
GB2089505A GB8136865A GB8136865A GB2089505A GB 2089505 A GB2089505 A GB 2089505A GB 8136865 A GB8136865 A GB 8136865A GB 8136865 A GB8136865 A GB 8136865A GB 2089505 A GB2089505 A GB 2089505A
Authority
GB
United Kingdom
Prior art keywords
reagent
transferrine
iron
sample
solid substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8136865A
Other versions
GB2089505B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCLAVO INST SIEROTERAPEUT
Original Assignee
SCLAVO INST SIEROTERAPEUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCLAVO INST SIEROTERAPEUT filed Critical SCLAVO INST SIEROTERAPEUT
Publication of GB2089505A publication Critical patent/GB2089505A/en
Application granted granted Critical
Publication of GB2089505B publication Critical patent/GB2089505B/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/90Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving iron binding capacity of blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The transferrine content of a sample is determined by adding to the sample a reagent consisting of a ferric salt adsorbed onto the particles of a suspension of a solid substrate, e.g. magnesium carbonate. The mixture obtained is centrifuged and the iron in the supernatant is determined e.g. colorimetrically. A reagent comprising a suspension of a solid substrate on which ferric salt is adsorbed is also claimed. <IMAGE>

Description

SPECIFICATION Determination of Transferrine This invention relates to a method for the determination of the iron-binding ability of transferrine, and to a reagent for use in the method.
Transferrine is a glycoprotein contained in blood. It serves to transfer iron, and each molecule thereof can bind two ferric ions.
The transferrine content of blood can be measured either directly by immunological methods, or indirectly by the determination of its iron-binding ability by chemical methods. With respect to the latter methods, there is known, from Clinica Chimica Acta, 2 221 (1957), a method which consists of the steps of (a) saturating the transferrine which is present in the sample, usually a serum sample, with an acidic solution which contains an excess of ferric ions, (b) removing, after incubation, the excess ferric ions by adding solid magnesium carbonate, and (c) determining, after centrifuging the slurry thus obtained, the amount of iron bonded to the transferrine contained in the supernatant, by means of a reagent suitable for the determination of iron.In other procedures, conversely, the excess amount of ferric ions is determined under appropiate conditions and the amount of iron removed by transferrine is then calculated, the amount of transferrine then being determined arithmetically.
We have now found that it is possible to determine the amount of tranferrine contained in a sample without previously saturating the sample with an excess of ferric ions in an acidic environment.
According to the present invention, there is provided a method of determining the transferrine content of a sample suspected of containing transferrine, which method comprises mixing the sample with a reagent comprising a suspension of a solid substrate on which substrate a ferric salt is absorbed, centrifuging the mixture, and determining the iron content of the resulting supernatant liquor.
The present invention also provides a reagent for use in determining the transferrine content of a sample suspected of containing transferrine, the reagent comprising a suspension of a solid substrate on which substrate a ferric salt Is adsorbed.
Thus, the present invention provides a method for the determination of the iron-binding ability of transferrine, in which method there is used a single reagent which comprises a solution of a ferric salt and a slurry of an appropriate solid adsorbant, the reagent being added to the sample whereafter the mixture is centrifuged and the iron bound to the transferrine contained in the supernatant is determined.
A number of advantages are achieved by the method of the invention, at least in preferred embodiments thereof, as compared to the prior art method outlined above. The most significant of them are (a) the procedure is simplified and the number of steps and incubation is lower; (b) fewer manipulative steps are required since it is not necessary to introduce magnesium carbonate in the solid state into the reaction mixture; (c) measurement of the amounts of reagent used is better reproducible; and (d) the tranferrine in the sample is saturated with ferric ions at a basic pH, the latter being suggested by the literature as the most suitable for the binding of transferrine to iron. We consider that these advantages result in a simplicity and an accuracy of determination which cannot be found in the prior art methods.
Preferably, the reagent has a pH of from 8 to 9, and accordingly it preferably contains a buffer capable of maintaining the pH at a value of from 8 to 9. The reagent preferably contains a colorimetric reagent for the determination of iron.
Examples of suitable solid substrates are basic magnesium carbonate and calcium carbonate, the former being preferred.
Examples of suitable buffers are H3PO4, H2PO-4, barbituric acid, and barbiturates. The preferred buffer is NaH2PO4.
If a colorimetric reagent is used, it can be a reagent known from the prior art. Also, it can be a reagent as disclosed and claimed in Italian Patent Application No. 201 77A/80, which was laid open to public inspection on the 26th August 1981.
The invention will now be illustrated by the following Examples.
Example 1 (Preparation of Reagent) In 100 ml of water there was dissolved 828 mg of NaH2PO4.H2O. Thereafter, 2.5 g of basic MgCO3 were added to form a suspension, and, to the suspension, there was added, with stirring, 1 ml of 0.01 normal HCI containing 500 mg/dl of Fe3+. The reagent was allowed to stand until its pH has stabilized.
Example 2 The reagent described in Example 1 was used for determing the iron-binding power of 48 samples of human blood serum. The average value was 293.71 micrograms/dl of iron, with a C.V. of 3.48%. In each of determinations, 1 ml of the reagent of Example 1 and 0.2 ml of serum were used, and incubation was carried out for 5 minutes at room temperature and centrifuging for 10 minutes at 4,000 RPM. The iron in the supernatant was drawn and determined with a conventional reagent Example 3 To fractional samples of a base serum whose iron-binding power had been determined, progressively increased amounts of human transferrine were added.The iron-binding power of the serum samples so enriched was determined according to the procedure set forth in Example 2 above and according to the Ramsey procedure disclosed in Clinica Chimica Acta, 2 221(1957). The values of the iron-binding power obtained by these two procedures were correlated with the amounts by weight of transferrine added, whereby graphs represented by the following equations were obtained: (A) y=0.90x+277.2 (correlation coefficient=0.998) (B) y=0.9 1 x+277.5 (correlation coefficient=0.997).
In the above equations, x is the amount of added tranferrine in milligrams and y is the ironbinding power in micrograms/dl of determined iron, equation (A) being that obtained by the procedure of Example 2 and equation (B) being that obtained by the Ramsey procedure.
The value of the iron-binding power of the base serum evaluated by the method of this invention was 281 micrograms/dl, and, by the Ramsay method, was 272 micrograms/dl, both these values being in satisfactory agreement with the values of the respective interceptions of the straight lines represented by the above equations.
The reagent used contained from 0.5 to 10 gidI of basic magnesium carbonate, from 1 to 100 mg/dl of Fe3+ and from 0 to 200 mg/litre of H2PO4.

Claims (12)

Claims
1. A method of determining the transferrine content of a sample suspected of containing transferrine, which method comprises mixing the sample with a reagent comprising a suspension of a solid substrate on which substrate a ferric salt is adsorbed, centrifuging the mixture, and determining the iron content of the resulting supernatant liquor.
2. A method according to claim 1, wherein the solid substrate is basic magnesium carbonate or calcium carbonate.
3. A method according to claim 1 or 2, wherein the reagent contains a buffer capable of maintaining the pH of the reagent at a value of from 8 to 9.
4. A method according to claim 3, wherein the buffer is phosphoric acid, a phosphate, barbituric acid or barbiturate.
5. A method according to any of claims 1 to 4, herein the reagent contains a colorimetric reagent for the determination of iron.
6. A method according to any of claims 1 to 5, wherein the sample comprises blood or blood serum.
7. A method according to claim 1, substantially as described in either of the foregoing Examples 1 and 2.
8. A reagent for use in determining the tranferrine content of a sample suspected of containing transferrine, the reagent comprising a suspension of a solid substrate on which substrate a ferric salt is adsorbed.
9. A reagent as claimed in claim 8, wherein the solid substrate is basic magnesium carbonate or calcium carbonate.
10. A reagent as claimed in claim 8 or 9, containing a buffer capable of maintaining the pH of the reagent at a value of from 8 to 9.
11. A reagent as claimed in claim 10, wherein the buffer is phophoric acid, a phosphate, barbituric acid or a barbiturate.
12. A reagent as claimed in any of claims 8 to 11, wherein the reagent contains a colorimetric reagent of the determination of iron.
1 3. A reagent as claimed in claim 8, substantially as described in either of the foregoing Examples 1 and 3.
GB8136865A 1980-12-11 1981-12-07 Determination of transferrine Expired GB2089505B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT26564/80A IT1148745B (en) 1980-12-11 1980-12-11 METHOD FOR DETERMINING TRANSFERRINE AND COMPOSITION SUITABLE FOR THE PURPOSE

Publications (2)

Publication Number Publication Date
GB2089505A true GB2089505A (en) 1982-06-23
GB2089505B GB2089505B (en) 1984-03-21

Family

ID=11219789

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8136865A Expired GB2089505B (en) 1980-12-11 1981-12-07 Determination of transferrine

Country Status (7)

Country Link
JP (1) JPS57122361A (en)
CA (1) CA1165215A (en)
DE (1) DE3147538C2 (en)
ES (1) ES508226A0 (en)
FR (1) FR2496270A1 (en)
GB (1) GB2089505B (en)
IT (1) IT1148745B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0137400A2 (en) * 1983-09-26 1985-04-17 Wako Pure Chemical Industries, Ltd. Determination of unsaturated iron-binding capacity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1239121B (en) * 1964-01-29 1967-04-20 Haury Chem Fab Dr Heinz Method for determining the total iron-binding capacity of body fluids, especially serum and urine
US3709985A (en) * 1969-07-17 1973-01-09 Abbott Lab Method for determining total blood serum iron-binding capacity
US3996162A (en) * 1970-02-27 1976-12-07 Nuclear Medical Laboratories, Inc. Analytical sorbent and method of use
JPS529160B2 (en) * 1972-04-12 1977-03-14
JPS5913521B2 (en) * 1975-06-19 1984-03-30 メイトウサンギヨウ カブシキガイシヤ Method for producing magnetic iron oxide/dextran complex
US4154929A (en) * 1976-08-16 1979-05-15 American Monitor Corporation 9-(2-Pyridyl)-acenaphtho[1,2-e]-as-triazines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0137400A2 (en) * 1983-09-26 1985-04-17 Wako Pure Chemical Industries, Ltd. Determination of unsaturated iron-binding capacity
EP0137400A3 (en) * 1983-09-26 1986-05-28 Wako Pure Chemical Industries, Ltd. Determination of unsaturated iron-binding capacity

Also Published As

Publication number Publication date
CA1165215A (en) 1984-04-10
ES8303698A1 (en) 1983-02-01
GB2089505B (en) 1984-03-21
JPS57122361A (en) 1982-07-30
JPH027429B2 (en) 1990-02-19
IT1148745B (en) 1986-12-03
ES508226A0 (en) 1983-02-01
FR2496270B1 (en) 1984-03-02
IT8026564A0 (en) 1980-12-11
DE3147538A1 (en) 1982-06-24
DE3147538C2 (en) 1983-09-08
FR2496270A1 (en) 1982-06-18

Similar Documents

Publication Publication Date Title
Weber et al. The binding of calcium to actomyosin systems in relation to their biological activity
Halfman et al. Measuring the binding of small molecules to protein from binding-induced alterations of physical-chemical properties
Tejwani et al. The purification of properties of rat liver fructose 1, 6-bisphosphatase
Lehmann Immunological relationship between human placentae and intestinal alkaline phosphatase
ZA832892B (en) Ascorbate-resistant broad range glucose test compositions,test device and method
EP0290269A3 (en) Immunoassay methods and reagents and methods for producing the latter
JP2000509486A (en) One-step all-in-one dry reagent immunoassay
US5482866A (en) Method for quantitation of calcium and magnesium and the novel reagent compositions
YU114287A (en) Process for specific determining content of serum fructosamine, as well as reagent mixture which is suitable for this process
EP0108400A2 (en) Determination of unsaturated thyroxine binding protein sites using fluorescence polarization techniques
US4486531A (en) Method and reagent for the determination of β-lipoprotein
Long et al. Kinetics and thermodynamics of the formation of glucose arsenate. Reaction of glucose arsenate with phosphoglucomutase
US4308027A (en) Method and composition for direct determination of iron in blood serum
CA1140439A (en) Quantitative testing for vitamin b in12 xx
CA1216216A (en) Procedure for the determination of peroxidase activity by end dilution titration and means for its realization
US4567150A (en) Method for determining transferrin and composition therefor
GB2089505A (en) Determination of Transferrine
US4810656A (en) Chromogenic reactive for determining the iron content and the iron-binding capacity of biological liquids
Mabuchi et al. Actomyosin ATPase. I. Quantitative measurement of activity in cryostat sections
US4786591A (en) Process for determining the binding capacity of thyroxin-binding globulin
US5219760A (en) Process for the determination of iron
CA1128857A (en) Dry composition of heavy metal cation with radiolabelled ligand and antibody
Hwang Interference of ATP and acidity in the determination of inorganic phosphate by the Fiske and Subbarow method
Jacobsson The effect of urea on the inhibition of trypsin by soybean trypsin inhibitor
US5443958A (en) 2-acrylamine-2-methyl-1-propanesulfonic acid enhancement of alkaline phosphatase label detection

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee